Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Sculpting a Uniquely Reactive Cysteine Residue for Site-Specific Antibody Conjugation

Journal Article · · Bioconjugate Chem.
Research Organization:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
Sponsoring Organization:
DOE - Office Of Science; NIH
OSTI ID:
1877208
Journal Information:
Bioconjugate Chem., Journal Name: Bioconjugate Chem. Journal Issue: (6) Vol. 33
Country of Publication:
United States
Language:
ENGLISH

References (22)

Site-Selective Antibody Functionalization via Orthogonally Reactive Arginine and Lysine Residues journal September 2019
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance journal June 2021
β-Lactam-based approach for the chemical programming of aldolase antibody 38C2 journal March 2009
Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody–Maytansinoid Conjugates journal June 2016
Site-Specific Antibody–Drug Conjugates in Triple Variable Domain Fab Format journal May 2020
Dual-mechanistic antibody-drug conjugate via site-specific selenocysteine/cysteine conjugation journal October 2019
Site-Specific Lysine Arylation as an Alternative Bioconjugation Strategy for Chemically Programmed Antibodies and Antibody–Drug Conjugates journal November 2019
Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates journal September 2014
Stable and Potent Selenomab-Drug Conjugates journal April 2017
Chemically programmed monoclonal antibodies for cancer therapy: Adaptor immunotherapy based on a covalent antibody catalyst journal April 2003
An Engineered Arginine Residue of Unusual pH-Sensitive Reactivity Facilitates Site-Selective Antibody Conjugation journal March 2021
Characterization and Higher-Order Structure Assessment of an Interchain Cysteine-Based ADC: Impact of Drug Loading and Distribution on the Mechanism of Aggregation journal February 2016
Direct Observation of an Enamine Intermediate in Amine Catalysis journal December 2009
A Humanized Aldolase Antibody for Selective Chemotherapy and Adaptor Immunotherapy journal September 2003
Antibody–Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs journal October 2015
Selective chemical protein modification journal September 2014
Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates journal October 2017
An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy journal September 2021
Rapid, Stable, Chemoselective Labeling of Thiols with Julia-Kocieński-like Reagents: A Serum-Stable Alternative to Maleimide-Based Protein Conjugation journal October 2013
Protein Modification, Bioconjugation, and Disulfide Bridging Using Bromomaleimides journal January 2010
Strategies and challenges for the next generation of antibody–drug conjugates journal March 2017
A Humanized Aldolase Antibody for Selective Chemotherapy and Adaptor Immunotherapy journal September 2003

Similar Records

Sculpting a Uniquely Reactive Cysteine Residue for Site-Specific Antibody Conjugation
Journal Article · 2022 · Bioconjugate Chem. · OSTI ID:1878392

Synthesis of site-specific antibody-drug conjugates by ADP-ribosyl cyclases
Journal Article · 2020 · Science Advances · OSTI ID:1834846

Cysteine-containing peptide tag for site-specific conjugation of proteins
Patent · 2008 · OSTI ID:1014528

Related Subjects